Updates in Infectious Disease: Spreading the Word

News
Slideshow

Opioids and infectious diseases, PrEP and STI risk, new oral Rx for C diff, and a shortage of ID specialists. We summarize studies, commentaries,  and reports on these topics and more.

Antibiotic resistance on the rise with infectious disease specialists in short supply, complicated medicine with complex patients, opioid epidemic begets infectious disease crisis-fresh new perspectives on these and other patient care issues and practices are being presented in recent reports and commentaries in leading journals. Click through the slides below for summaries of the ones that may affect primary care practice.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
Expert Insights: Q&A with Mark Ebell, MD, on Gepotidacin and UTI Management

Expert Insights: Q&A with Mark Ebell, MD, on Gepotidacin and UTI Management

Sydney Jennings
April 1st 2025
Article

Family physician and researcher Mark Ebell, MD, discusses the clinical implications, efficacy, and role of gepotidacin in UTI management.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

New Study Suggests Bacterial Vaginosis May be Sexually Transmitted

New Study Suggests Bacterial Vaginosis May be Sexually Transmitted

Sydney Jennings
March 28th 2025
Article

New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs

FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs

Sydney Jennings
March 25th 2025
Article

Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.

Study: 72% of Asymptomatic UTI Patients Receive Unnecessary Antibiotics

Study: 72% of Asymptomatic UTI Patients Receive Unnecessary Antibiotics

Sydney Jennings
March 21st 2025
Article

Researchers recommend expanding antimicrobial stewardship efforts to better track and reduce unnecessary antibiotic use.

© 2025 MJH Life Sciences

All rights reserved.